Empirico Company
Empirico is a developer of an insights platform designed to turn biological insights from human genetics into new medicines.
Funding Status:
Early Stage Venture
Industry:
Preclinical Development
Estimated Revenue:
$1M to $10M
Headquarters:
San Diego, California, United States
Total Funding:
29500000.0
Last Funding Date:
2020-01-09
Last Funding Type:
Series A
Employee Number:
11-50
Investors Number:
3.0
Founded Date:
2017-11-07